E-LIB Suche - Ergebnisse für: Michal Pochopien

1

Cost-Effectiveness Analysis of Innovative Therapies for Pat..:

Pochopien, Michal ; Dziedzic, Jakub Wladyslaw ; Aballea, Samuel...
Journal of Market Access & Health Policy. 12 (2024) 2 - p. 35-57 , 2024

Link: https://doi.org/10.3390/..

2

Cost-effectiveness of Finerenone in Addition to Standard of..:

Ming, Jian ; Hong, Guanqi ; Xu, Yingrui...
Advances in Therapy. , 2024

Link: https://doi.org/10.1007/..

3

A systematic review on the appropriate discounting rates fo..:

Qiu, Tingting ; Aballéa, Samuel ; Pochopień, Michal...
International Journal of Technology Assessment in Health Care. 40 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..

4

Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis ..:

Pochopien, Michal ; Tytuła, Anna ; Toumi, Mondher...
Advances in Therapy. 41 (2024) 6 - p. 2307-2323 , 2024

Link: https://doi.org/10.1007/..

5

The impact of amortization of gene therapies funding on the..:

Polek, Hubert ; Janik, Justyna ; Paterak, Ewelina...
Journal of Market Access & Health Policy. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

6

Cost-effectiveness of finerenone in chronic kidney disease ..:

Quist, Sara W. ; van Schoonhoven, Alexander V. ; Bakker, Stephan J. L....
Cardiovascular Diabetology. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Cost‐effectiveness of recombinant factor VIII Fc versus emi..:

Kragh, Nana ; Tytula, Anna ; Pochopien, Michał...
European Journal of Haematology. 110 (2022) 3 - p. 262-270 , 2022

Link: https://doi.org/10.1111/..

8

Cost-minimization analysis of recombinant factor VIII Fc ve..:

Mancuso, Maria Elisa ; Castaman, Giancarlo ; Pochopien, Michal...
Journal of Medical Economics. 25 (2022) 1 - p. 1068-1075 , 2022

Link: https://doi.org/10.1080/..

9

Gene Therapy Evidence Generation and Economic Analysis: Pra..:

Qiu, Tingting ; Pochopien, Michal ; Liang, Shuyao...
Frontiers in Public Health. 10 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

Efficacy and Safety of Avatrombopag in Patients with Chroni..:

Wojciechowski, Piotr ; Wilson, Koo ; Nazir, Jameel...
Advances in Therapy. 38 (2021) 6 - p. 3113-3128 , 2021

Link: https://doi.org/10.1007/..

11

An overview of health technology assessments of gene therap..:

Pochopień, Michał ; Paterak, Ewelina ; Clay, Emilie...
Journal of Market Access & Health Policy. 9 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

12

Cost-effectiveness of fluocinolone acetonide implant (ILUVI..:

Pochopien, Michal ; Beiderbeck, Annette ; McEwan, Phil...
BMC Health Services Research. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

13

Oncology from an HTA and Health Economic Perspective:

, In: Regulatory and Economic Aspects in Oncology; Recent Results in Cancer Research,

Francois, Clement ; Zhou, Junwen ; Pochopien, Michał.. - p. 25-38 , 2018

Link: https://doi.org/10.1007/..

14

The impact of amortization of gene therapies funding on the..:

Hubert Polek ; Justyna Janik ; Ewelina Paterak...
https://www.tandfonline.com/doi/10.1080/20016689.2023.2232648. , 2023

Link: https://doi.org/10.1080/..

15

Cost-effectiveness of finerenone in chronic kidney disease ..:

Sara W. Quist ; Alexander V. van Schoonhoven ; Stephan J. L. Bakker...
https://doi.org/10.1186/s12933-023-02053-6. , 2023

Link: https://doi.org/10.1186/..